Effects of Myo-inositol in poor responder patients undergoing intracytoplasmic sperm injectio

Phase 2

• Conditions: oninflammatory disorders of female genital tract.; Complication associated with artificial fertilization, unspecified; N98.9

• Registration Number: IRCT20160722029027N8
• Lead Sponsor: Vice Chancellor for research of Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 148

Inclusion Criteria

Age below 45 years
Body mass index (BMI) between 20-30
low ovarian reserve [both ovarian AFC below 7 or AMH below 1.1 ng/ml or low ovarian response in previous cycle (below 3 oocyte)
none history of allergy to Myo-inositol

Exclusion Criteria

unwillingness to continue

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of metaphase II oocyte. Timepoint: Time of oocyte pick up. Method of measurement: According to embryolog criteria.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum ßHcG test.

Secondary Outcome Measures

Name	Time	Method
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Vision fetal heart beat in ultrasound.